At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Control/Sham Treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Heat Therapy to Reduce Leg Pain and Improve Walking Tolerance in Patients With Symptomatic Peripheral Artery Disease
In Brief
A clinical study evaluating Control/Sham Treatment and Heat Therapy (HT) for Peripheral Arterial Disease. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate whether exposure to heat therapy improves calf muscle oxygenation and enhances walking tolerance in patients with symptomatic Peripheral Arterial Disease (PAD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesUnited States
CollaboratorsRoseguini, Bruno, PhD, Michael Emery, MD
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartAug 2018
Primary CompletionAug 2019
TodayJul 2026
First PostedFeb 19, 2018
Enrollment StartAug 1, 2018
Primary CompletionAug 14, 2019
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 8.4 years ago
Interventions
Control/Sham Treatmentdevice
Water at 33ºC was circulated through water-circulating trousers.
Heat Therapy (HT)device
Water at 42-43ºC was circulated through the water-circulating trousers.